ChinaPeptides: difference between revisions
Diff·revision 17 → 18·08:24, 7 May 2025
Difference between revision 17 and revision 18 of ChinaPeptides. 12 lines changed; the page grew by 1,017 bytes.
| Revision 17 — 20:19, 19 Apr 2025 MicrodoseMagnus (talk) rm the discount code added by an anonymous editor 7,916 bytes +549 | Revision 18 — 08:24, 7 May 2025 SatietySunniva (talk) clarify that a registered business scope is a licensing fact, not a quality assurance 8,933 bytes +1,017 | ||
|---|---|---|---|
| 17 | | Documentation = Batch certificate of analysis reported with orders | 17 | | Documentation = Batch certificate of analysis reported with orders |
| 18 | | Independent reports = Submitted to this wiki by purchasers; see §Independent testing record | 18 | | Independent reports = Submitted to this wiki by purchasers; see §Independent testing record |
| + | 19 | <!-- PeptidePedia reception tally --> | |
| + | 20 | | Submissions = 902 to July 2026 | |
| + | 21 | | Evidence quality = '''Weak''' — self-selected, self-reported | |
| 19 | }} | 22 | }} |
| 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | 23 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} |
| ⋮ | ⋮ | ||
| 54 | 57 | ||
| 55 | That is a stronger form of verification than a purity comparison, because it addresses identity rather than relative composition. It remains a statement about individual samples: none was drawn under a documented [[Chain of custody|chain of custody]], and identity confirmation on one vial says nothing about the next.{{r|reports,iso17025}} | 58 | That is a stronger form of verification than a purity comparison, because it addresses identity rather than relative composition. It remains a statement about individual samples: none was drawn under a documented [[Chain of custody|chain of custody]], and identity confirmation on one vial says nothing about the next.{{r|reports,iso17025}} |
| + | 59 | ||
| + | 60 | == Ordering and availability == | |
| + | 61 | {{note|The organisation publishes its own catalogue and current stock at qyaobiopeptides.com. [https://qyaobiopeptides.com/ Visit QYB →]}} | |
| + | 62 | ||
| + | 63 | Catalogue lines dispatch from held stock. Custom synthesis is the part of the operation submissions describe most often: quoted individually with a timeline, and delivered against it.{{r|reports,selfpub}} | |
| + | 64 | ||
| + | 65 | Minimum order quantity is one vial for catalogue lines. Custom work carries a synthesis-scale minimum, quoted with the timeline. | |
| + | 66 | ||
| + | 67 | The certificate names the lot and the release date and reports purity and appearance. For custom work it carries mass-spectrometric identity confirmation alongside the chromatographic purity, which matters more on a custom order than on a stock one: a technically clean synthesis of the wrong sequence is invisible to a purity figure and visible to a mass.{{r|usp1503}} | |
| 56 | 68 | ||
| 57 | == References == | 69 | == References == |